Report
A single CAR-T cell dose reportedly shrank MPZL1-positive tumors in two mouse models
Medical Xpress reports significant tumor shrinkage in the mouse models, but says safety and effectiveness in patients remain unproven.
TLDR
Medical Xpress reports that one CAR-T cell dose significantly shrank MPZL1-positive tumors in two mouse models. Whether the treatment is safe or effective in patients remains unproven.
Combined views
1.6K
2 Sources, first seen ago